Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Solid Organ Transplant: early-phase trial registry

1 of 5 indexed Solid Organ Transplant trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Solid Organ Transplant: 5 US clinical trials tracked, 1 recruiting.

Solid Organ Transplant is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Arkansas Children's Hospital Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition solid-organ-transplant

OPEN 1 | RECR 20% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Solid Organ Transplant (this)20%
Open-enrollment share among volume-matched conditions near Solid Organ Transplant

Solid Organ Transplant lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Solid Organ Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Solid Organ Transplant is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Solid Organ Transplant research.

    Arkansas Children's Hospital Research Institute accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Solid Organ Transplant trials plan to enrol fewer than 100 people.

    Median target enrolment is 74 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Solid Organ Transplant splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Named interventions

Most-linked intervention names on Solid Organ Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fluzone High-Dose - 1 dose of HD Drug
1 trials
Fluzone High-Dose - 2 doses Drug
1 trials
Viral Specific T-cells (VSTs) Biological
1 trials
High Dose Quadrivalent Inactivated Influenza Vaccine Biological
1 trials
Standard Dose Quadrivalent Inactivated Influenza Vaccine Biological
1 trials

US sites by state

Facility locations filed on Solid Organ Transplant trials. A trial with sites in several states counts in each.

Tennessee 3 trials
Ohio 2 trials
Minnesota 2 trials
South Carolina 1 trials
Pennsylvania 1 trials
New York 1 trials
Nebraska 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Solid Organ Transplant page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Solid Organ Transplant condition card totals 5 registered trials; most-linked intervention Fluzone High-Dose - 1 dose of HD; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.